Stability of peptide nucleic acids in human serum and cellular extracts.

The stability of a new type of DNA mimic, peptide nucleic acid (PNA) in human blood serum, Eschericia coli and Micrococcus luteus extracts and nuclear and cytoplasmic extracts from mouse Ehrlich ascites tumor cells was investigated using HPLC analysis. Under conditions that caused complete cleavage of a control peptide, adrenocorticotropic hormone fragment 4-10, no significant degradation of the PNAs, H-T10-LysNH2 and H-TGTACGTCACAACTA-NH2, could be detected. Similarly, PNA H-T5-LysNH2 was found to resist attack by fungal proteinase K or porcine intestinal mucosa peptidase at concentrations exceeding those necessary to completely degrade a control peptide, H-Phe-Trp-Tyr-Cys-Phe-Trp-Tyr-Lys-Phe-Trp-Tyr-Lys-OH, by at least 1000- and 30-fold, respectively. Thus PNA is expected to have sufficient biostability to be used as a drug.

[1]  M. Egholm,et al.  Sequence selective double strand DNA cleavage by peptide nucleic acid (PNA) targeting using nuclease S1. , 1993, Nucleic acids research.

[2]  J. Steitz,et al.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Peter E. Nielsen,et al.  Peptide nucleic acids (PNA) : oligonucleotide analogues with an achiral peptide backbone , 1992 .

[4]  A. Mirzabekov,et al.  [Nature of the enzyme relaxing superhelical DNA and isolated in a histone H1 fraction]. , 1977, Doklady Akademii nauk SSSR.

[5]  M. Egholm,et al.  Sequence specific inhibition of DNA restriction enzyme cleavage by PNA. , 1993, Nucleic acids research.

[6]  A. Kaplan,et al.  Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. , 1989, Biochemical pharmacology.

[7]  Oligonucleotide-based therapeutics , 1991, Nature.

[8]  R. H. Berg,et al.  Peptide nucleic acids containing adenine or guanine recognize thymine and cytosine in complementary DNA sequences , 1993 .

[9]  M. Egholm,et al.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. , 1991, Science.

[10]  S. Mizutani,et al.  Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme , 1991, Peptides.

[11]  R. Skidgel,et al.  Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Turner Aj.  Processing and metabolism of neuropeptides. , 1986 .

[13]  T. Friedman,et al.  The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum. , 1985, Biochemical and biophysical research communications.

[14]  R. H. Berg,et al.  Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA) , 1992 .

[15]  M. Egholm,et al.  Peptide nucleic acids (PNAs): potential antisense and anti-gene agents. , 1993, Anti-cancer drug design.

[16]  Peter E. Nielsen,et al.  PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules , 1993, Nature.

[17]  O. Carretero,et al.  Contributions of various rat plasma peptidases to kinin hydrolysis. , 1989, The Journal of pharmacology and experimental therapeutics.

[18]  R. Skidgel.  Basic carboxypeptidases: regulators of peptide hormone activity. , 1988, Trends in pharmacological sciences.

[19]  V. Potaman,et al.  N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes. , 1991, Biochemical and biophysical research communications.

[20]  M. Spillantini,et al.  Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid. , 1990, Biochemical pharmacology.

[21]  R. Kole,et al.  Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. , 1991, Life sciences.

[22]  J. Bisi,et al.  Antisense and antigene properties of peptide nucleic acids. , 1992, Science.

[23]  A. Panconesi,et al.  Enkephalinase and angiotensin converting enzyme activities in human venous and arterial plasma , 1986, Neuropeptides.

[24]  E. Uhlmann,et al.  Antisense oligonucleotides: a new therapeutic principle , 1990 .

[25]  N. Tomilin,et al.  Substrate specificity of the ultraviolet-endonuclease from Micrococcus luteus. Endonucleolytic cleavage of depurinated DNA. , 1976, European journal of biochemistry.